Skin lipids may slow repair by blocking immune recognition and its repair signal
In adult human skin, layered lipid formulations may improve the water barrier while suppressing recognition of CD1a and the interleukin-22 signal proposed to enable repeated repair. Human skin organ culture would reject this chain if repair stayed slow after confirmed restoration of the immune signal.
Stage of verification
- Hypothesis published2026-09-26
- Indirect evidenceAssessed at 4 of 10
- Direct testAwaited
Map of the hypothesis
Hover over an icon or tap it to see its name.
Where in the body
Ageing mechanism
Kind of knowledge gap
A double ring marks the main placement where a group contains several values.
Target map
Every target of every published hypothesis, each with the actions a hypothesis can propose on it. The targets and the actions of this hypothesis are drawn solid.

Immune cell
CD1a-reactive T cells
T cells that recognize CD1a and provide an immune signal involved in epidermal barrier repair
Where this hypothesis actsHuman skin after repeated friction and drying under lamellar lipid treatment
Hypotheses on this target 1
Activation1
Clearance restoration
Reprogramming
Adoptive transfer
Elimination
Immunosuppression
Population balance

What is proposed
Activation
Briefly activate CD1a-reactive T cells after mechanical stress
With whatNot stated in the record
HowShort activation of autologous CD1a-reactive T cells after stress; the activation technique is not stated
Possible result
Expected reversal of delayed barrier recovery
From the recordКороткая активация аутологичных CD1a-реактивных Т-клеток после нагрузки должна устранить задержку

Receptor or channel
CD1a
A lipid-binding molecule on Langerhans cells recognized by autoreactive T cells
Where this hypothesis actsLangerhans cells in human skin exposed to lamellar formulations containing long-chain sphingomyelins
Hypotheses on this target 1
Lower level
Higher level
Blockade1
Agonism
Desensitisation
Function restoration
Function preservation

What is proposed
Blockade
Block recognition of CD1a to test its role in barrier recovery
With whatSmall molecule
HowCD1a blockade in the control group; matched lamellar formulations also vary in their lipids' ability to block CD1a recognition
Possible result
Expected reproduction of delayed barrier recovery
From the recordБлокада CD1a в контрольной группе должна воспроизвести задержку.

Signalling molecule
Interleukin-22
An immune signalling molecule implicated in epidermal barrier recovery after microinjury
Where this hypothesis actsHuman skin after stress and brief activation of autologous CD1a-reactive T cells
Hypotheses on this target 1
Lower level
Synthesis suppression
Neutralisation1
Supplementation
Accelerated excretion

What is proposed
Neutralisation
Block interleukin-22 to test whether it mediates restored barrier recovery
With whatNot stated in the record
HowInterleukin-22 blockade after T-cell activation; the blocking agent is not stated
Possible result
Expected loss of the recovery restored by T-cell activation
From the recordблокада интерлейкина-22 должна отменить это восстановление.
All targets of the lab
Every target read from the published hypotheses, each kind around its pictogram. A larger mark means more hypotheses act on that target. Point at a mark and the actions proposed on it branch out of it.
Solid and named: the targets of this hypothesis
Explore in depth
The logic
The train of thought that ends in this hypothesis. Each stage is the reason the next exists. The master question narrows to a goal, the goal to an unknown nobody has closed, the unknown to the hypothesis proposed here. Every step below says what it rests on and what carries it.
Skin that holds water better between everyday stresses might still recover more slowly after repeated rubbing and drying. The unexpected move is to attribute that mismatch to treatment fats blocking immune recognition, rather than to weakened connections between skin cells or chemical damage to those cells. This is a hypothesis generated by the pipeline, not a measured treatment effect.
- The proposal begins with a layered fat treatment improving the skin's resting resistance to water loss.
- Long-chain sphingomyelins in some formulations are proposed to increase the share of CD1a-bound lipids that inhibit immune recognition.
- After minor damage, those bound lipids are proposed to shift the immune response from a brief repair signal to a suppressed signal.
- Reduced T-cell activation is proposed to diminish the early interleukin-22 pulse.
- Loss of that pulse is proposed to slow recovery after subsequent rubbing and drying, despite preserved lipid organization.
- Briefly restoring the immune signal is predicted to restore recovery without requiring a change in immune-cell numbers or composition.
A building can have a better waterproof roof while its damage alarm is muffled. It stays dry in ordinary weather, but repairs after each storm start too slowly.
Where the picture breaks: The picture separates water protection from a repair signal, but skin has no single alarm or repair crew. Whether the proposed immune signal is necessary for recovery is precisely what remains unestablished.
- Master questionstep 01 of 04
The aim is a treatment that brings the skin function of middle-aged people closer to that of young people.
Rests on: The supplied goal explicitly makes youthful skin function the treatment target.
Stated in the chain - Goal pillarstep 02 of 04
The treatment target adds a ten-year restoration criterion for skin function.
Rests on: The master question supplies the comparison with younger skin, but no ten-year criterion.
AssumptionA ten-year criterion is taken as given. The supplied text does not clarify whether this means reversing a decade of functional decline or maintaining restored function for a decade.
- Gap questionstep 03 of 04
Lamellar lipid therapy, a treatment using fats arranged in layers, might reduce resting water loss while slowing recovery after repeated rubbing and drying, even when the layered fat structure has been restored.
Rests on: The broader goal concerns restored skin function; this stage selects a possible conflict between holding water at rest and recovering after stress.
LeapThe preceding stage supplies no reason for selecting layered fat treatments or this particular conflict as the route to its ten-year target. The supplied sources do not establish that treatment-induced conflict.
- Hypothesisstep 04 of 04
Some treatment fats are proposed to suppress a brief immune signal needed for repeated repair. The proposed route involves CD1a, cluster of differentiation 1a, a protein that holds lipids for recognition by immune cells; Langerhans cells, immune cells in the skin's outer living layer; and autoreactive T cells, immune cells that respond to the body's own molecular structures. The treatment is proposed to reduce their release of interleukin-22, an immune messenger, without requiring a change in immune-cell numbers or in which cell families are present.S3S4
Rests on: The gap supplies the proposed mismatch between resting protection and recovery. S3, in Nature Immunology (2010), describes CD1a-dependent interleukin-22 production in cell cultures, but does not establish that this signal is necessary for skin repair. S4, available here only as an abstract from The British Journal of Dermatology (2026), reports that processing inhibitory long-chain sphingomyelin, a lipid with a long molecular tail, promoted CD1a-directed immune activity; it does not establish the proposed treatment effect or repair sequence.
Supported by literature
What is carried, and what is not. Screened sources speak to two component relationships: lipid-dependent inhibition of CD1a recognition and CD1a-linked production of interleukin-22. S4's 2026 dermatology abstract addresses the first without testing treatment-induced repair delay, and S3's 2010 Nature Immunology cell-culture work addresses the second without showing repair necessity; neither establishes the sequence from applying a formulation to impaired recovery.S4S3
Where the reasoning is carried by something unstated · 2
- Goal pillar. A ten-year criterion is taken as given. The supplied text does not clarify whether this means reversing a decade of functional decline or maintaining restored function for a decade.
- Gap question. The preceding stage supplies no reason for selecting layered fat treatments or this particular conflict as the route to its ten-year target. The supplied sources do not establish that treatment-induced conflict. Establish the missing link before relying on this step.
How a result here could mislead · 3
- A formulation could suppress the immune signal and also cause chemical damage to skin cells; delayed recovery could then be credited entirely to immune suppression. Matching initial damage, hydration, lipid organization and crack growth does not establish equal chemical damage. What closes it: The comparison must also assess oxidation, chemical reactions that damage fats, and associated cell damage across repeated stresses. The design does not specify those measurements, although oxidative damage is one of its stated rivals.
- Failure of immune stimulation to restore recovery could mean that the proposed mechanism is wrong, or that the cultured skin no longer contains functioning cells capable of delivering the intended signal. What closes it: The experiment must verify functioning Langerhans cells and same-donor T cells through repeated stresses, and confirm restoration of the early interleukin-22 signal before treating persistent delay as a refutation. The supplied design explicitly identifies cell preservation as a technical difficulty.
- Reduced immune activation could be mistaken for evidence that inhibitory lipids occupy CD1a when the intervention instead reduces the amount of CD1a available for recognition. S5, in Scientific Reports (2017), reports altered CD1a location and reduced presentation after pollutant exposure in human immune cells, but does not establish that a skin formulation acts this way.S5 What closes it: The proposed measurement of CD1a-bound lipid composition must be accompanied by measurement of CD1a availability at the cell surface. Otherwise, lipid occupancy and protein availability remain competing explanations for reduced recognition.
What would make this wrong. The supplied hypothesis identifies persistent repair delay after confirmed restoration of the brief immune signal as a refutation of its causal sequence, provided the initial damage, hydration, lipid organization and crack growth remain comparable. The input does not define the named recovery indicator or specify a numerical threshold for successful restoration, so neither can be supplied here.
What it would change. If the mechanism held, improving skin function would require assessing recovery after repeated stress alongside resting water retention, because a formulation could improve one while impairing the other. Treatment composition would also need to preserve the proposed brief repair signal. Results in human skin maintained outside the body would still not establish rejuvenation in middle-aged people, the full range of youthful skin functions, or either interpretation of the ten-year target.
Sources read · 8
Group A Streptococcus induces CD1a-autoreactive T cells and promotes psoriatic inflammation. · Science immunology · 2023
“However, the presence of CD1a promoted the production of IL-22 and IFNγ from both CD4 + and CD8 + draining lymph node T cells after GAS infection ( ).”
Does not settle: Источник не устанавливает восстановление эпидермального барьера у взрослых людей, роль клеток Лангерганса при микроповреждении, действие ламеллярных составов или длинноцепочечных сфингомиелинов, потерю воды, повторные нагрузки либо SPV_1. Сообщение об интерлейкине-22 относится к модели инфекции стрептококком у CD1a-трансгенных мышей.
Phospholipase activity of acyloxyacyl hydrolase induces IL-22-producing CD1a-autoreactive T cells in individuals with psoriasis. · European journal of immunology · 2022
“We found that the PLA 2 activity of rAOAH leads to the activation of circulating CD1a auto‐reactive T cells, leading to the production of IFN‐γ and IL‐22.”
Does not settle: Источник оставляет открытыми необходимость краткого сигнала CD1a-аутореактивных Т-клеток для повторного восстановления эпидермального барьера у взрослых людей, влияние ламеллярных составов и длинноцепочечных сфингомиелинов, связывание тормозящих липидов с CD1a, потерю воды, скорость восстановления после нагрузки, состав связанных с CD1a липидов и показатель SPV_1.
CD1a-autoreactive T cells are a normal component of the human αβ T cell repertoire. · Nature immunology · 2010
“CD1a dependent cytokine gene upregulation was measured by real-time PCR.”
Does not settle: Источник описывает CD1a-зависимую продукцию IL-22 в культурах Т-клеток и антигенпредставляющих клеток, но не устанавливает необходимость этого сигнала для восстановления эпидермального барьера у взрослых людей после микроповреждения. Он не проверяет ламеллярные составы, длинноцепочечные сфингомиелины, липиды, связанные с CD1a, потерю воды, повторные нагрузки, SPV_1 или независимость механизма от численности и клонального состава иммунных клеток.
CD1a-autoreactive T cell sensing of skin barrier compromise. · The British journal of dermatology · 2026
“Activated skin DCs expressed neutral sphingomyelinase, which processed inhibitory long chain sphingomyelin to drive Th2 cell CD1a-autoreactivity.”
Does not settle: Источник не устанавливает, что у взрослых людей повторное восстановление эпидермального барьера требует краткого сигнала аутореактивных Т-клеток или интерлейкина-22. В абстракте отсутствуют данные о ламеллярных составах, потере воды, скорости восстановления после последующих нагрузок, SPV_1 и независимости механизма от численности или клонального состава иммунных клеток.
Inhibition of endocytic lipid antigen presentation by common lipophilic environmental pollutants. · Scientific reports · 2017
“These observations strongly support that the CD1a protein begins to be retained in recycling endosomes at the low BaP concentration and is further retained in early endosomes at the high concentration, suggesting the contribution of altered endocytic gene expression to the reduced lipid antigen presentation, lower CD1a expression, and inhibited T cell activation.”
Does not settle: Источник исследует воздействие бензо[a]пирена на человеческие дендритные клетки, а не ламеллярные составы, длинноцепочечные сфингомиелины, клетки Лангерганса или восстановление эпидермального барьера у взрослых людей. Он не устанавливает роль аутореактивных Т-клеток, интерлейкина-22, потери воды, замедления последующего восстановления, состава липидов, связанных с CD1a, или SPV_1.
IgG regulates the CD1 expression profile and lipid antigen-presenting function in human dendritic cells via FcgammaRIIa. · Blood · 2008
“Finally, the ability of DCs to activate CD1-restricted NKT cells and T cells was determined by this regulatory effect of IgG.”
Does not settle: Источник описывает влияние IgG на профиль CD1 и активацию T-клеток in vitro в человеческих дендритных клетках. Он не устанавливает восстановление эпидермального барьера у взрослых людей, участие клеток Лангерганса, связывание сфингомиелинов с CD1a, интерлейкин-22, скорость восстановления после микроповреждения или SPV_1.
The CD1 size problem: lipid antigens, ligands, and scaffolds. · Cellular and molecular life sciences : CMLS · 2014
“individual lipids can act as stimulatory antigens, inhibitory ligands, or space-filling scaffolds.”
Does not settle: This review abstract does not establish effects in adult human epidermis, Langerhans cells, autoreactive T cells, interleukin-22, barrier-repair kinetics, sphingomyelin formulations, or SPV_1.
CD1-restricted microbial lipid antigen-specific recognition found in the CD8+ alpha beta T cell pool. · Journal of immunology (Baltimore, Md. : 1950) · 1999
“Here, we report two human CD8+ TCR alphabeta+ T cell lines specific for Mycobacterium tuberculosis Ags presented in the context of CD1a or CD1c Ag-presenting molecules.”
Does not settle: Источник описывает две линии человеческих CD8+ Т-клеток, распознающих липидные антигены Mycobacterium tuberculosis через CD1a или CD1c. Он не устанавливает роль аутореактивных Т-клеток, клеток Лангерганса, интерлейкина-22, сфингомиелинов, восстановления эпидермального барьера или SPV_1.
The gap this hypothesis explains
Two live hypotheses pull in opposite directions here, and the field has not chosen between them.
Can layered skin fats reduce resting water loss yet slow recovery after repeated rubbing and drying?
Original wording · exactly as the pipeline generated it
Может ли ламеллярная липидная терапия снижать потерю воды в покое и одновременно ухудшать восстановление после повторного трения и высушивания, даже при подтверждённом восстановлении липидной организации?
What this question is asking
The question concerns whether a skin treatment can improve water retention while making recovery from everyday wear slower. It asks whether delivering fats in layers to middle-aged human skin reduces water escaping at rest but worsens recovery after repeated rubbing and drying, compared with skin without that treatment. It specifically asks whether these effects could coexist even when the arrangement of fats in the skin has been confirmed as restored. The pipeline assumes that the proposed treatment already improves surface measurements and asks whether those improvements could conceal poorer recovery; the supplied sources do not establish that treatment-specific premise.
- Lamellar lipid therapy
- A treatment described here as delivering skin fats in layers. 'Lamellar' means layered and 'lipid' means fat or a fat-like substance; the supplied material does not specify the formulation.
- RL-3
- The pipeline’s label for the proposed treatment. Its identity, composition and the meaning of the label are not supplied.
- Resting water loss
- Water escaping through the skin when it is not undergoing the rubbing or drying challenge. A lower value describes water retention at that time and does not, by definition, measure later recovery.
- Skin barrier or permeability barrier
- The skin’s ability to limit passage of substances, including outward passage of water. The question focuses on water retention and restoration of that function after disturbance.
- Lipid organization
- The arrangement of fats within the skin’s outer layer, including their formation into layers. 'Restored' requires a reference arrangement and a measurement criterion, neither of which is specified here.
- Functional resilience and recovery
- The ability to maintain function during disturbance and regain it afterward. These involve degrees and timescales rather than a single yes-or-no state; the pipeline supplies no numerical limits.
- Epidermis and laboratory epidermal equivalents
- The epidermis is the outer part of the skin. Laboratory equivalents are experimental models of it; S1 studies these models rather than treated middle-aged people.
- Relative humidity
- The amount of water vapour in air relative to what it could hold at the same temperature. S1 changes this environmental condition, which is different from the question’s repeated rubbing-and-drying exposure.
- Occlusion and occlusive membrane
- Occlusion means covering the skin to restrict exchange with its surroundings, including water escape. S2 uses a covering membrane; the supplied evidence does not establish that the proposed fat treatment acts like that membrane.
- Tissue fluid
- Fluid within body tissues. The pipeline invokes it as a possible explanation for misleading surface measurements, but the supplied sources do not establish that role.
- Acetone
- A solvent used in the mouse experiment described for S2. That exposure differs from the proposed everyday rubbing and drying.
- Stratum corneum and keratin
- The stratum corneum is the outermost skin layer, containing structural proteins called keratins and an arrangement of fats. S3 reports incomplete organization of these components despite wound closure.
- Hairless mice, pigs and mammals
- Mice and pigs are the animal systems used in S2 and S3. Both belong, with humans, to the broader group called mammals; that shared membership does not establish identical treatment responses.
- Friction and mechanical stress
- Friction is rubbing between surfaces; mechanical stress includes forces that deform or wear the skin. The question concerns function after repeated exposure, whereas the supplied S7 finding establishes increased water loss after disturbance.
- Younger-skin range
- The range of function in younger people proposed as the comparison target. The input supplies neither age boundaries nor measured reference values.
Lamellar delivery of RL-3 improves surface indicators, while occlusion and tissue-fluid mechanisms allow those indicators to diverge from functional resilience.
The pipeline describes RL-3 as a treatment delivered in layers of fats and assumes that it improves measurements taken at the skin surface. It also proposes that covering the skin to restrict water escape, or changes in fluid within the tissue, could make those measurements look better without improving recovery from wear. That assumption supplies the proposed reason why apparent restoration might coexist with poorer performance.
The supplied search results do not establish an effect of RL-3 or identify its composition. S2 reports abnormal recovery under an occlusive membrane in animals, and S3 reports wound closure despite incomplete organization of outer-skin components; neither establishes the proposed treatment-specific mechanism or a role for tissue fluid. Confirmed restoration of lipid organization is a condition in the question, not a treatment result demonstrated by these sources. This absence of supporting results does not establish that the premise is false.S2S3
The same question asked without the part nothing read establishes:
- Does layered skin-fat treatment in middle-aged humans reduce resting water loss while slowing recovery after repeated rubbing and drying, compared with untreated skin?
- When layered skin-fat treatment restores the arrangement of fats in middle-aged human skin, how does recovery after repeated rubbing and drying compare with untreated skin?
- Less resting water loss, slower recovery If fat organization were also restored, the treatment would improve water retention at rest while leaving the skin slower to recover after disturbance. Resting water loss and fat arrangement would therefore be insufficient, by themselves, to establish recovery comparable to younger skin.
- Less resting water loss, unchanged or faster recovery The improvement in water retention would occur without the proposed recovery penalty under the conditions assessed. Whether recovery reached the younger-skin range would still depend on that comparison, which the supplied material does not provide.
- The combined effect is not established If reduced resting water loss or restored fat organization were absent, poorer recovery would not demonstrate the particular combination the question asks about. The treatment could have other effects, but they would not settle whether successful structural restoration conceals impaired recovery.
Fats in the skin’s outer layer help limit water escape, so their arrangement is relevant to its protective barrier, as described in S4. Rubbing can increase water loss, as reported in S7, making recovery after disturbance a separate concern from water retention at rest. If treatment lowered resting water loss while delaying recovery, that resting measurement alone could give a misleading impression of protection during repeated use. If recovery instead remained intact or improved, attributing harm to the treatment on the basis of indirect animal findings would also be misleading.
Ламеллярная доставка RL-3 улучшает поверхностные показатели; узлы окклюзии и тканевой жидкости допускают расхождение этих показателей с функциональной устойчивостью.
Барьер и механическая функция сохраняют молодой диапазон после повторных нагрузок; скорость восстановления остаётся в заранее заданных пределах.
Не проверено, может ли подтверждённая нормализация липидной структуры сопровождаться причинным ухудшением восстановления при повторной бытовой нагрузке.
The mechanism it proposes
The engine's own statement of the hypothesis, in full.
Проверяемая гипотеза: повторное восстановление эпидермального барьера у взрослого человека требует короткого сигнала от аутореактивных Т-клеток, распознающих молекулу CD1a на клетках Лангерганса. Некоторые ламеллярные составы, содержащие длинноцепочечные сфингомиелины, одновременно восстанавливают водный барьер и увеличивают связывание тормозящих липидов с CD1a. Это подавляет необходимый импульс интерлейкина-22 после микроповреждения. Поэтому потеря воды в покое снижается, а восстановление после следующих нагрузок замедляется при сохранённой организации липидов. Носителем нарушения служит состав липидов, связанных с CD1a; изменение численности или клонального состава иммунных клеток для этого механизма не требуется. Восстановление краткого иммунного сигнала должно стабилизировать SPV_1.
Testing and possible results
The prediction that would tell it apart
A hypothesis that predicts what its rivals predict is not worth running an experiment over. This is the observation on which this one differs.
В органной культуре кожи человека сравнивают ламеллярные составы с одинаковыми барьерными и механическими свойствами, но различной способностью их липидов блокировать распознавание CD1a. Гипотеза предсказывает замедление восстановления только у состава, который повышает долю тормозящих липидов на CD1a и подавляет ранний иммунный ответ. Блокада CD1a в контрольной группе должна воспроизвести задержку. Короткая активация аутологичных CD1a-реактивных Т-клеток после нагрузки должна устранить задержку; блокада интерлейкина-22 должна отменить это восстановление. Исходная величина повреждения, гидратация, липидная организация и рост микротрещин должны оставаться сопоставимыми. Сохранение задержки после подтверждённого восстановления иммунного сигнала опровергнет предложенную причинную цепь.
Would tell it apart from at least one rival. The prediction specifies comparative recovery outcomes, responses to interventions, and an explicit rejection condition. These are measurable without numerical thresholds. No rival prediction is supplied. Only a bench experiment would settle it.
What testing it would take
The engine's own read on whether this is testable with methods that already exist.
Связывание липидов с CD1a, активацию Т-клеток и восстановление барьера можно исследовать в человеческих клеточных системах и органной культуре кожи. Главная техническая трудность состоит в сохранении функциональных клеток Лангерганса и аутологичных Т-клеток при повторных нагрузках. Иммунные вмешательства сначала проверяются вне организма. Результаты обычной мышиной модели недостаточны для проверки человеческой системы CD1a.
Other explanations
Every other hypothesis the engine wrote for the same gap, and the observation that would separate the two.
В органной культуре кожи человека сравнивают ламеллярные составы с одинаковыми барьерными и механическими свойствами, но различной способностью их липидов блокировать распознавание CD1a. Гипотеза предсказывает замедление восстановления только у состава, который повышает долю тормозящих липидов на CD1a и подавляет ранний иммунный ответ. Блокада CD1a в контрольной группе должна воспроизвести задержку. Короткая активация аутологичных CD1a-реактивных Т-клеток после нагрузки должна устранить задержку; блокада интерлейкина-22 должна отменить это восстановление. Исходная величина повреждения, гидратация, липидная организация и рост микротрещин должны оставаться сопоставимыми. Сохранение задержки после подтверждённого восстановления иммунного сигнала опровергнет предложенную причинную цепь.
- Rival 01 of 02What would separate them
Lamellar lipid therapy may slow skin repair by weakening contacts between outer skin cells predicts: На изолированном роговом слое человека после обработки и удаления остатков средства должны наблюдаться ускоренный рост межклеточных трещин и снижение числа циклов до потери герметичности. Эффект должен сохраняться без живого эпидермиса и иммунных клеток при одинаковых гидратации, температуре и измеренной механической нагрузке. Параметры, оценённые на одной серии нагрузок, должны предсказывать рост трещин на независимой серии с другой амплитудой. В живой ткани задержка восстановления должна зависеть от накопленной длины трещин. Отсутствие дополнительного роста трещин при сохранённой задержке восстановления опровергнет эту гипотезу как основное объяснение.
- Rival 02 of 02What would separate them
Oxidation of treatment lipids may damage skin cells and slow recovery after friction and drying predicts: В органной культуре сравнивают исходный состав с вариантом, в котором окисляемая линолевая кислота заменена эквимолярным аналогом с дейтерием в бис-аллильных положениях. До нагрузки подтверждают сопоставимые включение липидов, ламеллярную организацию, потерю воды, гидратацию, механические свойства и активность системы CD1a. Гипотеза предсказывает, что изотопная замена уменьшит образование гидропероксидов и белковых аддуктов и устранит задержку восстановления при неизменном первоначальном механическом повреждении. Снижение окислительных продуктов без улучшения восстановления опровергнет их ведущую причинную роль. Возникновение эффекта только при сильном искусственном окислительном воздействии не подтвердит объяснение бытовой уязвимости.
Why this is not the mainstream account
The engine is asked to say what its hypothesis would overturn and what would surprise a specialist. This is its answer.
В здоровой коже обнаружены CD1a-аутореактивные Т-клетки, способные выделять интерлейкин-22. Отдельно показано, что сфингомиелин 42:2, в отличие от некоторых более коротких видов, резко подавляет взаимодействие CD1a с Т-клеточными рецепторами. Эти наблюдения допускают независимое изменение физического барьера и иммунного распознавания, но сами по себе не подтверждают предложенную задержку восстановления. [de Jong и соавторы, 2010](https://pmc.ncbi.nlm.nih.gov/articles/PMC3131223/); [Cotton и соавторы, 2021](https://pmc.ncbi.nlm.nih.gov/articles/PMC8111460/).
Физиология эпидермального барьера. Пересмотра потребовала бы глава 124 «Skin Barrier and Transdermal Drug Delivery», особенно раздел о липидном обмене и восстановлении барьера: в последовательность восстановления пришлось бы включить обязательный адаптивный иммунный этап даже при достаточном синтезе липидов, нормальной секреции ламеллярных телец и восстановленной липидной организации. [Глава Prausnitz и соавторов](https://www.dermascope.com/wp-content/uploads/2014/03/Prausnitz-Derm-Book-Chapter-2012-693.pdf).
Краткая активация аутореактивных Т-клеток полностью возвращает нормальную скорость восстановления после повторного трения, хотя дополнительное введение правильно организованных липидов не помогает; специфическая блокада CD1a делает ранее устойчивую кожу уязвимой без предшествующего нарушения липидной организации.
В целевом поиске не найдено утверждения, что подавление CD1a-аутореактивности ламеллярной терапией вызывает обязательный срыв повторного восстановления при нормальной липидной организации. Общая связь CD1a с гомеостазом кожи и возможность подавления Т-клеток липидами уже описаны; новизна здесь ограничена утверждением об обязательности этого этапа и указанной причине терапевтического ухудшения. Отсутствие публикаций во всей литературе не доказано, поэтому статус HERETICAL предварительный.
What stands behind it
Which of the figures above have a study behind them, which are the engine's own, and what it would take to refute the hypothesis. This audit never judges the idea.
This hypothesis states no figure and cites no study, so there is nothing here to trace.
What it would take to refute it. Nothing already retrieved carries the prediction’s terms and it names no measurement this layer can route to a public dataset, so the bench is the residual — not a finding against it.
0 citation handles extracted; 1 Europe PMC search run; 0 records examined; 0 sources stored for enrichment, 0 with full text. A citation that did not resolve is a bibliographic failure, not proof that no such paper exists, and no hypothesis is blocked by this audit.